← Leaderboards
Mark P. Dunphy
Sloan-Kettering Inst Can Research
$3,061,237
Attributed
$8,430,661
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,430,661 · 3
By mechanism
RF1$4,816,476 · 1
R01$2,877,920 · 1
R21$736,265 · 1
Top collaborators
- Gabriela Chiosis8 shared
- Monica L Guzman5 shared
- Jason S Lewis5 shared
- Nagavarakishore Pillarsetty3 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Gabriela Chiosis$23,584,161
- Alexander Drilon$4,847,187
- Jason S Lewis$26,024,327
- John Thomas Poirier$4,490,380
- Ping Chi$18,562,542
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImagePharmaceutical PreparationsValidationIn VivoMolecularCollaborationsPositron-Emission TomographyClinical TrialsUptakeAlzheimer&AposLabelBiological MarkersProteinsClinicRadiotracerMouse ModelClinical ResearchFuturePre-Clinical ModelCancer PatientMedicalMalignant Breast NeoplasmMalignant NeoplasmsMemorial Sloan-Kettering Cancer Center
Grant awards (10)
[18F]-PU-AD epichaperome PET imaging probe$845,131
RF1 · FY2025 · AG
[18F]-PU-AD epichaperome PET imaging probe$381,564
RF1 · FY2025 · AG
[18F]-PU-AD epichaperome PET imaging probe$3,589,781
RF1 · FY2022 · AG
Biomarkers for predicting response to Hsp90 therapy$572,232
R01 · FY2017 · CA
Biomarkers for predicting response to Hsp90 therapy$573,509
R01 · FY2016 · CA
Biomarkers for predicting response to Hsp90 therapy$599,324
R01 · FY2015 · CA
Biomarkers for predicting response to Hsp90 therapy$550,587
R01 · FY2014 · CA
Biomarkers for predicting response to Hsp90 therapy$582,268
R01 · FY2013 · CA
First Human Trial of Src/Abl-Targeted PET Tumor Imaging with F-18 SKI-249380$356,747
R21 · FY2013 · CA · contact PI
First Human Trial of Src/Abl-Targeted PET Tumor Imaging with F-18 SKI-249380$379,518
R21 · FY2012 · CA · contact PI